LENZ Therapeutics, Inc. (LENZ) Misses Q2 EPS by 40c

LENZ Therapeutics, Inc. (NASDAQ: LENZ) reported Q2 EPS of ($0.40).

For earnings history and earnings-related data on LENZ Therapeutics, Inc. (LENZ) click here.

You May Also Be Interested In

• ​SpaceX plans to launch new AI model with Cursor - The Information
• JPMorgan Reiterates Underweight Rating on DSM-Firmenich AG (DSFIR:NA), Places on Negative CW
• Penguin Solutions (PENG) Tops Q2 EPS by 28c, Beats on Revenue; Offers FY26 EPS Guidance